Interaction of TNF with Angiotensin II Contributes to Mitochondrial Oxidative Stress and Cardiac Damage in Rats

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Mariappan, Nithya ^a   Elks, Carrie M ^b   Haque, Masudul ^a   Francis, Joseph ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR TYPE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; LOSARTAN; MITOCHONDRIAL COMPLEX II; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CONTROLLED STUDY; CYTOSOL; DIASTOLIC DYSFUNCTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; ECHOCARDIOGRAPHY; ELECTRON SPIN RESONANCE; ENZYME SYNTHESIS; GENE EXPRESSION; HEART DISEASE; HEART INJURY; HEART LEFT VENTRICLE FUNCTION; HEART MITOCHONDRION; MALE; MITOCHONDRIAL GENE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; TISSUE LEVEL;

EID: 84867304024     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046568     Document Type: Article

References (49)

1. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, et al. (2008) Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients. New England Journal of Medicine 359: 2417-2428.
2. Fujita T, Ando K, Nishimura H, Ideura T, Yasuda G, et al. (2007) Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int 72: 1543-1549.
3. Granger DN, Vowinkel T, Petnehazy T, (2004) Modulation of the Inflammatory Response in Cardiovascular Disease. Hypertension 43: 924-931.
4. Schiffrin EL, Touyz RM, (2003) Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade. J Am Coll Cardiol 42: 911-913.
5. Pohjoismäki JL, Boettger T, Liu Z, Goffart S, Szibor M,et al. Oxidative stress during mitochondrial biogenesis compromises mtDNA integrity in growing hearts and induces a global DNA repair response. Nucleic Acids Research.
6. Jolda-Mydlowska B, Salomon P, (2003) [Cytokines and remodeling of the heart in patients with congestive heart failure]. Pol Arch Med Wewn 109: 23-33.
7. Sriramula S, Haque M, Majid DSA, Francis J, (2008) Involvement of Tumor Necrosis Factor-{alpha} in Angiotensin II-Mediated Effects on Salt Appetite, Hypertension, and Cardiac Hypertrophy. Hypertension 51: 1345-1351.
8. Turner NA, Das A, Warburton P, O'Regan DJ, Ball SG, et al. (2009) Interleukin-1{alpha} stimulates proinflammatory cytokine expression in human cardiac myofibroblasts. Am J Physiol Heart Circ Physiol 297: H1117-1127.
9. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, et al. (2002) Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int 62: S12-S22.
10. Wolf G, Neilson EG, (1993) Angiotensin II as a renal growth factor. J Am Soc Nephrol 3: 1531-1540.
11. Mariappan N, Soorappan RN, Haque M, Sriramula S, Francis J, (2007) TNF-alpha-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol. Am J Physiol Heart Circ Physiol 293: H2726-2737.
12. Mariappan N, Elks CM, Fink B, Francis J, (2009) TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction. Free Radical Biology and Medicine 46: 462-470.
13. Frohlich ED, (2004) Target organ involvement in hypertension: a realistic promise of prevention and reversal. Med Clin North Am 88: 209-221.
14. Ichihara S, Senbonmatsu T, Price E, Ichiki T, Gaffney FA, et al. (2001) Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II-Induced Hypertension. Circulation 104: 346-351.
15. Sriramula S, Haque M, Majid DSA, Francis J, (2008) Involvement of Tumor Necrosis Factor-α in Angiotensin II-Mediated Effects on Salt Appetite, Hypertension, and Cardiac Hypertrophy. Hypertension 51: 1345-1351.
16. Zhang GX, Lu XM, Kimura S, Nishiyama A, (2007) Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovasc Res 76: 204-212.
17. Hitomi H, Kiyomoto H, Nishiyama A (2007) Angiotensin II and oxidative stress. Current Opinion in Cardiology 22: 311-315 310.1097/HCO.1090b1013e3281532b3281553.
18. Oskarsson HJ, Heistad DD, (1997) Oxidative Stress Produced by Angiotensin Too: Implications for Hypertension and Vascular Injury. Circulation 95: 557-559.
19. Dai D-F, Hsieh EJ, Liu Y, Chen T, Beyer RP, et al. (2012) Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress. Cardiovascular Research 93: 79-88.
20. Guggilam A, Haque M, Kerut EK, McIlwain E, Lucchesi P, et al. (2007) TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am J Physiol Heart Circ Physiol 293: H599-609.
21. Guggilam A, Patel KP, Haque M, Ebenezer PJ, Kapusta DR, et al. (2008) Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur J Heart Fail 10: 625-634.
22. Mariappan N, Elks CM, Sriramula S, Guggilam A, Liu Z, et al. (2009) NF-{kappa}B-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res.
23. Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, et al. (2005) Rotenone Model of Parkinson Disease. Journal of Biological Chemistry 280: 42026-42035.
24. Dikalov SI, Dikalova AE, Mason RP, (2002) Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine. Arch Biochem Biophys 402: 218-226.
25. Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, et al. (2005) Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem 280: 42026-42035.
26. Flarsheim CE, Grupp IL, Matlib MA, (1996) Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol Heart Circ Physiol 271: H192-202.
27. Moe GW, Marin-Garcia J, Konig A, Goldenthal M, Lu X, et al. (2004) In vivo TNF-{alpha} inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. Am J Physiol Heart Circ Physiol 287: H1813-1820.
28. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, et al. (1998) Inhibitory Effects of Antioxidants on Neonatal Rat Cardiac Myocyte Hypertrophy Induced by Tumor Necrosis Factor-{alpha} and Angiotensin II. Circulation 98: 794-799.
29. Woo C-H, Eom Y-W, Yoo M-H, You H-J, Han HJ, et al. (2000) Tumor Necrosis Factor-α Generates Reactive Oxygen Species via a Cytosolic Phospholipase A2-linked Cascade. Journal of Biological Chemistry 275: 32357-32362.
30. Olivares-Reyes JA, Arellano-Plancarte A, Castillo-Hernandez JR, (2009) Angiotensin II and the development of insulin resistance: Implications for diabetes. Molecular and Cellular Endocrinology 302: 128-139.
31. Li J-M, Shah AM, (2003) ROS Generation by Nonphagocytic NADPH Oxidase: Potential Relevance in Diabetic Nephropathy. J Am Soc Nephrol 14: S221-226.
32. Girouard H, Park L, Anrather J, Zhou P, Iadecola C, (2007) Cerebrovascular Nitrosative Stress Mediates Neurovascular and Endothelial Dysfunction Induced by Angiotensin II. Arterioscler Thromb Vasc Biol 27: 303-309.
33. Lehoux S, (2006) Redox signalling in vascular responses to shear and stretch. Cardiovasc Res 71: 269-279.
34. Taniyama Y, Griendling KK, (2003) Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms. Hypertension 42: 1075-1081.
35. Gurevitch J, Frolkis I, Yuhas Y, Lifschitz-Mercer B, Berger E, et al. (1997) Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 30: 1554-1561.
36. Higashi Y, Chayama K, Yoshizumi M, (2005) Angiotensin II type I receptor blocker and endothelial function in humans: role of nitric oxide and oxidative stress. Curr Med Chem Cardiovasc Hematol Agents 3: 133-148.
37. Touyz RM, (2004) Reactive oxygen species and angiotensin II signaling in vascular cells: implications in cardiovascular disease. Brazilian Journal of Medical and Biological Research 37: 1263-1273.
38. Millatt LJ, Abdel-Rahman EM, Siragy HM, (1999) Angiotensin II and nitric oxide: a question of balance. Regulatory Peptides 81: 1-10.
39. Suzuki H, Eguchi K, Ohtsu H, Higuchi S, Dhobale S, et al. (2006) Activation of Endothelial Nitric Oxide Synthase by the Angiotensin II Type 1 Receptor. Endocrinology 147: 5914-5920.
40. Csont T, Viappiani S, Sawicka J, Slee S, Altarejos JY, et al. (2005) The involvement of superoxide and iNOS-derived NO in cardiac dysfunction induced by pro-inflammatory cytokines. Journal of Molecular and Cellular Cardiology 39: 833-840.
41. Funakoshi H, Kubota T, Machida Y, Kawamura N, Feldman AM, et al. (2002) Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol 282: H2159-2166.
42. Madonna R, Di Napoli P, Massaro M, Grilli A, Felaco M, et al. (2005) Simvastatin Attenuates Expression of Cytokine-inducible Nitric-oxide Synthase in Embryonic Cardiac Myoblasts. Journal of Biological Chemistry 280: 13503-13511.
43. Ebadi M, Sharma SK, (2003) Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxid Redox Signal 5: 319-335.
44. Kumarswamy R, Chandna S, (2009) Putative partners in Bax mediated cytochrome-c release: ANT, CypD, VDAC or none of them? Mitochondrion 9: 1-8.
45. Hofer T, Servais S, Seo AY, Marzetti E, Hiona A, et al. (2009) Bioenergetics and permeability transition pore opening in heart subsarcolemmal and interfibrillar mitochondria: Effects of aging and lifelong calorie restriction. Mechanisms of Ageing and Development 130: 297-307.
46. Atlante A, Calissano P, Bobba A, Azzariti A, Marra E, et al. (2000) Cytochrome c Is Released from Mitochondria in a Reactive Oxygen Species (ROS)-dependent Fashion and Can Operate as a ROS Scavenger and as a Respiratory Substrate in Cerebellar Neurons Undergoing Excitotoxic Death. Journal of Biological Chemistry 275: 37159-37166.
47. Duncan JG, Fong JL, Medeiros DM, Finck BN, Kelly DP, (2007) Insulin-Resistant Heart Exhibits a Mitochondrial Biogenic Response Driven by the Peroxisome Proliferator-Activated Receptor-{alpha}/PGC-1{alpha} Gene Regulatory Pathway. Circulation 115: 909-917.
48. Russell LK, Mansfield CM, Lehman JJ, Kovacs A, Courtois M, et al. (2004) Cardiac-Specific Induction of the Transcriptional Coactivator Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1{alpha} Promotes Mitochondrial Biogenesis and Reversible Cardiomyopathy in a Developmental Stage-Dependent Manner. Circ Res 94: 525-533.
49. Dai D-F, Rabinovitch PS, Ungvari Z, (2012) Mitochondria and Cardiovascular Aging. Circulation Research 110: 1109-1124.